BCM
DMTX

Bridgeway Capital Management’s Dimension Therapeutics, Inc DMTX Stock Holding History

Bridgeway Capital Management’s Portfolio DMTX Stock Details DMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-50,800
Closed -$305K – 1512
2017
Q3 		$305K Hold
50,800
– – ﹤0.01% 1202
2017
Q2 		$74K Sell
50,800
-4,520
-8% -$6.14K ﹤0.01% 1374
2017
Q1 		$97K Buy
55,320
+13,920
+34% +$36.9K ﹤0.01% 1336
2016
Q4 		$180K Hold
41,400
– – ﹤0.01% 1327
2016
Q3 		$331K Buy
41,400
+20,000
+93% +$145K ﹤0.01% 1219
2016
Q2 		$128K Buy
+21,400
New +$163K ﹤0.01% 1366

Bridgeway Capital Management's DMTX Position: Q4 2017 in Review

Bridgeway Capital Management sold out of Dimension Therapeutics, Inc (DMTX) in Q4 2017, closing a stake of 50,800 shares — an estimated $305K sold.

Bridgeway Capital Management first reported a position in DMTX in Q2 2016 and held it in 6 quarters. The position peaked at $331K in Q3 2016. 0 funds tracked by Wall St. Rank hold DMTX as of Q4 2017.

  • Bridgeway Capital Management reported no remaining Dimension Therapeutics, Inc position as of Q4 2017 after selling out during the quarter.
  • Bridgeway Capital Management sold 50,800 Dimension Therapeutics, Inc shares in Q4 2017, an estimated $305K.
  • Bridgeway Capital Management first reported a position in Dimension Therapeutics, Inc in Q2 2016 and held it in 6 quarters.
  • Bridgeway Capital Management's Dimension Therapeutics, Inc position peaked at $331K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q4 2017.

Based on Bridgeway Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.